Podcast Summaries
Not transcripts. For each episode we pull the key claims, separate established evidence from the speaker's opinion, keep the actual numbers, and say what it means for a carrier, with a link to listen in full.
Michael Davidson and Peter Attia discuss lifelong LDL lowering, obicetrapib's trial results, and what the Alzheimer's blood-marker findings mean for APOE4 carriers.
With Michael Davidson, M.D.
A lipid researcher explains why CETP inhibitors may matter for ApoE4 carriers' brain and heart risk, plus how ApoE4 drives higher LDL.
With John Kastelein, M.D., Ph.D. (professor of genetic medicine, University of Amsterdam)
A practical roundtable on resistance training, protein targets, injury-smart programming, and muscle as a metabolic organ that matters for carriers.
With Dr. Gabrielle Lyon (fellowship-trained in geriatrics and nutritional sciences), Mike Boyle (strength and conditioning coach), Jeff Cavaliere (physical therapist, former New York Mets PT)
Dr. Tom Dayspring on how the brain handles cholesterol separately from the body, why APOE4 disrupts it, and what statins, ezetimibe, omega-3s, and CETP inhibitors may mean for carriers.
With Tom Dayspring, M.D. (lipidologist)
Neuroscientist Tommy Wood on dementia prevention, omega-3 plus B vitamins, open-skill exercise, VO2 max, and creatine. What's solid vs speculative for carriers.
With Dr. Tommy Wood (associate professor of pediatrics and neuroscience, University of Washington; PhD physiology and neuroscience; head of research for Food for the Brain; CSO of BetterBrain)
Biochemist Rhonda Patrick on why APOE4 carriers may need a different omega-3 strategy, and what the evidence really says about sauna, exercise, and dementia.
With Rhonda Patrick, Ph.D.
Neuroscientist Lisa Mosconi argues menopause is a neurological event that can trigger Alzheimer's in susceptible women, and explains what the evidence does and does not show.
With Dr. Lisa Mosconi, PhD
Attia's Outlive interview with Tim Ferriss on apoB and heart risk, VO2 max and mortality, and exercise as the strongest lever against Alzheimer's risk.
With Dr. Peter Attia, MD (founder of Early Medical; host of The Drive)
Sleep scientist Matthew Walker on how deep sleep clears amyloid and tau, why deep sleep declines with age, and the levers carriers can pull.
With Dr. Matthew Walker, PhD (professor of neuroscience, UC Berkeley; director, Center for Human Sleep Science)
Physician Peter Attia on the lipid and vascular links to Alzheimer's, why ApoB matters for the brain, and his case for exercise and Zone 2. (APOE4 is not named.)
With Peter Attia, M.D.
A USC lipid researcher on how APOE4 raises Alzheimer's risk, the energy and DHA-transport problems carriers face with age, and what the evidence does and does not support.
With Hussein Yassine, M.D. (associate professor of medicine, Keck School of Medicine at USC; lipid metabolism and Alzheimer's researcher)
A neurologist and a 3/4 carrier patient walk through the lifestyle, supplement, and hormone levers used to lower Alzheimer's risk in APOE4 carriers.
With Lauren Miller Rogen (co-founder, Hilarity for Charity/HFC), Richard Isaacson, M.D. (director, Alzheimer's Prevention Clinic, Weill Cornell)
A neuroscientist argues late-onset Alzheimer's is driven by impaired blood flow and mitochondrial energy failure, not amyloid, and discusses methylene blue, near-infrared light, and ketones.
With Francisco Gonzalez-Lima, Ph.D. (professor of neuroscience, pharmacology and toxicology, University of Texas at Austin)
Attia stress-tests Dave Feldman's lipid energy model and the lean mass hyper-responder, with apoB and apoE4 relevance for carriers.
With Dave Feldman (engineer, n=1 self-experimenter, founder of cholesterolcode.com)